Address: 7th floor, No. 69, Lane 77, Xing-Ai Road, Neihu, Taipei,Taiwan
Tel: +886 2 2790 0799
Web: http://www.chifupharma.com/
Chi-Fu Trading Co., Ltd. provides turnkey solutions to manufacturers worldwide who are interested in entering the Taiwanese and Asian markets. Chi-Fu carefully researchs the markets, and communicates with customers. Chi-Fu also evaluates potential products for our clients in the Asian markets. With the combined efforts of manufacturers and our marketing staff, Chi-Fu improves the health of the citizens and enhances its suppliers’ market portfolios.
Chi-Fu Trading Co., Ltd. Will transform from its existing stage into “Chi-Fu Multinational Enterprise” to better reflect our market representations as well as our diverse product lines.
We stride to become a leader in distributing highly sophisticated medical equipment, devices, pharmaceuticals, consumables and bio technology related products.
We will hold leadership positions in all of our product and service areas and become the leader in all of the markets that we are present.
Chi-Fu will engage and become a leader in the health promotion service and hospital management consultation, working toward improving the health care of mankind.
Lee-Cheng (L-C) Liu, President and CEO of EirGenix, one of Taiwan’s fastest growing companies in the biotech field, documents the progress made in the set-up of EirGenix’s new commercial biomanufacturing…
Jui-Lin Chen, CEO of MiCareo, provides insights into the development of MiSelect, Micareo’s pioneering platform for the analysis of Circulating Tumor Cells (CTC) and other rare cells, which proudly stands…
Chen Min-Che, founder and managing director of Asclepiumm, provides insights into the main milestones reached and the new partnership opportunities considered by this exciting biotech company, whose Antibody Switch-on Cytotoxicity…
Freddie Höglund, CEO of the European Chamber of Commerce Taiwan (ECCT), and Mike Exton, Managing Director of Novartis Taiwan and Co-Chair of the Pharmaceutical Committee of the ECCT, document the…
Mike Exton, Managing Director at Novartis Taiwan, describes the affiliate’s plans to increase collaboration with the government in order to provide Taiwanese patients with a greater access to innovative, life-changing…
Petar Vazharov, Alvogen’s executive vice president for Asia Pacific, and, Jefferson Wang, general manager of Lotus, provide insights into Lotus’ tremendous evolution from a local generics company into a regional…
The Chairman & CEO of TaiGen Biotechnology discusses the growth opportunities that the company holds in China, its main target market, and documents how her long-term strategic outlook made the…
Yung Fa Chen, ScinoPharm’s President and CEO, documents his strategy to drive the Taiwan-based global success story to new heights, having established itself as an indisputable leader in the API…
JCP is home to over five decades of generic medication production and is a cornerstone household brand for numerous products in Taiwan’s domestic market, most notably with CNS medications. The…
Fangchen Lee, Chairman of YungShin Global Holding on strengthening the groups’s vertical integration, expanding product portfolio, and instilling a collaborative approach in the local generics industry, with the vision to build a Taiwan-based pharmaceutical…
Hong-Jen Chang, former Deputy Minister of Health and current CEO and Chairman of the YFY Biotech Management Company, a Taiwan-based VC fund which has been playing an instrumental role in…
George Lee and Tzu-Ming Pan introduce SunWay Biotech’s groundbreaking red yeast rice extract, ANKASCIN® 568-R, which has been recognized as a New Dietary Ingredient by the US FDA. SunWay Biotech…
See our Cookie Privacy Policy Here
